# US 10,306,922 B2 · Systems and methods for quantification of, and prediction of smoking behavior

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 10,306,922 B2
- Document ID: US10306922B2
- Status: Granted
- Kind: B2
- Application number: 15/092,475
- Filed: 2016-04-06
- Published: 2017-03-02
- Granted: 2019-06-04
- Earliest claimed: 2015-04-07
- Assignees: Carrot, Inc.
- Applicants: Carrot Sense, Inc.
- Inventors: David S. Utley; Allen Jameson; Jennifer Marler
- Web page: https://patentgrep.com/patent/US10306922B2

## CPC

- A24F 47/00: Smokers' requisites not otherwise provided for
- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/021: Measuring pressure in heart or blood vessels
- A61B 5/02405: {Determining heart rate variability}
- A61B 5/02438: {with portable devices, e.g. worn by the patient}
- A61B 5/0533: Measuring galvanic skin response
- A61B 5/0816: {Measuring devices for examining respiratory frequency (measuring frequency of electric signals G01R23/00)}
- A61B 5/082: {Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath (A61B5/083, A61B5/091 take precedence)}
- A61B 5/083: Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
- A61B 5/097: Devices for facilitating collection of breath or for directing breath into or through measuring devices
- A61B 5/14551: {for measuring blood gases}
- A61B 5/4266: {sweat secretion}
- A61B 5/681: {Wristwatch-type devices}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- G01N 33/497: of gaseous biological material, e.g. breath
- G08B 21/12: responsive to undesired emission of substances, e.g. pollution alarms
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 40/67: for remote operation
- H04Q 9/00: Arrangements in telecontrol or telemetry systems for selectively calling a substation from a main station, in which substation desired apparatus is selected for applying a control signal thereto or for obtaining measured values therefrom
- A61B 2562/046: in a matrix array
- H04Q 2209/40: using a wireless architecture
- H04W 84/18: Self-organising networks, e.g. ad-hoc networks or sensor networks
- A24F: SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES (inhaling appliances for medical purposes, shaped like cigars, cigarettes or pipes A61M15/06)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G08B: SIGNALLING SYSTEMS, e.g. PERSONAL CALLING SYSTEMS; ORDER TELEGRAPHS; ALARM SYSTEMS
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- H04Q: SELECTING (switches, relays, selectors H01H; wireless communication networks H04W)
- H04W: WIRELESS COMMUNICATION NETWORKS (broadcast communication H04H; communication systems using wireless links for non-selective communication, e.g. wireless extensions H04M1/72)

## Abstract

Systems and methods for monitoring of biometric and contextual variables to assist in screening for, quantification of, and prediction of smoking behavior, and for assisting in smoking cessation are described.

## Claims

### Claim 1

A method of preparing a program to cease smoking for a patient who smokes, the method comprising:
measuring at least one biological indicator determinative of whether the patient smoked;
capturing a plurality of patient data, where the patient data comprises information correlated in time to when the patient smoked;
combining at least one of the plurality of patient data and at least one biological indicator to assess a smoking behavior of the patient during a first testing period, where the first testing period occurs while the patient is smoking as usual prior to a quit attempt; and
integrating the smoking behavior into a quit program; and
providing a report of the quit program.

### Claim 2

The method of 1, where measuring at least one biological indicator comprises capturing a plurality of samples of exhaled air from the patient over the first testing period.

### Claim 3

The method of 1, where assessing the smoking behavior comprises correlating a function of exhaled carbon monoxide versus time over a period of time.

### Claim 4

The method of 3, further comprising obtaining an area of exhaled carbon monoxide and time under a curve defined by the function over the first testing period.

### Claim 5 (depends on 1)

The method of claim 1, where capturing the plurality of patient data further comprising generating a signal to the patient to provide at least one sample of exhaled air.

### Claim 6

The method of 1, where capturing the plurality of patient data further comprising alerting the patient on a repeating basis to provide the sample of exhaled air over the first testing period.

### Claim 7 (depends on 1)

The method of claim 1, where capturing the plurality of patient data further comprising receiving an input data from the patient and recording a time of the input.

### Claim 8 (depends on 7)

The method of claim 7, where the input data comprises at least a count of a portion of a cigarette smoked by the patient.

### Claim 9 (depends on 8)

The method of claim 8, where providing the report further comprises displaying a summation of the count of a portion of the cigarettes smoked by the patient.

### Claim 10 (depends on 8)

The method of claim 8, further comprising determining a cigarette cost using the count of the portion of cigarettes smoked by the patient and displaying the cigarette cost.

### Claim 11 (depends on 8)

The method of claim 8, further comprising determining a nicotine estimate using the count of the portion of cigarettes smoked by the patient and displaying the nicotine estimate.

### Claim 12 (depends on 7)

The method of claim 7, where the patient data comprises a behavioral information of the patient.

### Claim 13 (depends on 1)

The method of claim 1, where providing the report further comprises providing a visual display of an exhaled carbon monoxide load in association with a visual display interval of time within the first testing period.

### Claim 14 (depends on 2)

The method of claim 2, where providing the report further comprises providing a visual display of a count of a number of the plurality of samples of exhaled air.

### Claim 15 (depends on 1)

The method of claim 1, where providing the report further comprises determining a series of exhaled carbon monoxide loads for a series of intervals of time within the first testing period.

### Claim 16 (depends on 15)

The method of claim 15, further comprising displaying the series of exhaled carbon monoxide loads for the series of intervals of time.

### Claim 17 (depends on 1)

The method of claim 1, where measuring an amount of exhaled carbon monoxide comprises using a portable sensor.

### Claim 18 (depends on 17)

The method of claim 17, further comprising transmitting the amount of exhaled carbon monoxide and the collection time associated with each sample of exhaled air from the portable sensor to an electronic device.

### Claim 19 (depends on 2)

The method of claim 2, further comprising obtaining a location of the patient when obtaining at least one of the plurality of samples of exhaled air.

### Claim 20 (depends on 1)

The method of claim 1, further comprising obtaining a result of a behavioral questionnaire from the patient.

### Claim 21 (depends on 1)

The method of claim 1, where providing the report comprises quantifying an exposure of exhaled carbon monoxide over an interval of time within a period of time and estimating a rate of decay of carbon monoxide.

### Claim 22 (depends on 1)

The method of claim 1, where providing the report comprises quantifying an exposure of exhaled carbon monoxide over an interval of time within the first testing period and estimating an increase in a rate of carbon monoxide in the event the patient smokes a cigarette.

### Claim 23 (depends on 1)

The method of claim 1, where assessing the smoking behavior comprises assessing a degree of intervention required for the quit program.